NCT04874857

Brief Summary

This study is a randomized controlled and single-blind study consisting of qualitative and quantitative stages to evaluate the effect of aromatherapy massage on cramp frequency, cramp pain severity and quality of life in crampy hemodialysis (HD) patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
94

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 25, 2020

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

April 21, 2021

Completed
15 days until next milestone

First Posted

Study publicly available on registry

May 6, 2021

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 28, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 28, 2022

Completed
Last Updated

January 10, 2023

Status Verified

January 1, 2023

Enrollment Period

2.1 years

First QC Date

April 21, 2021

Last Update Submit

January 7, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Visual Analog Scala (VAS)

    The widespread use of VAS, which has been used in the research of subjective concepts from past years to the present, has been realized after in 1969. This scale; There is a number value of "0 (no pain)" at the beginning and "10 (the most unbearable pain)" at the end. The patient marks the severity of the cramp he is experiencing at that moment, and the starting and ending points of the scale as criteria. A VAS value between 1-3 means "mild pain", between 4-6 means "moderate pain", and a value between 7-10 means "severe pain". Participants will mark the scale each time they experience a cramp.

    During 1 month

Secondary Outcomes (1)

  • Quality of Life Index Dialysis Version - III

    At the first and last meeting in 1 month

Study Arms (3)

Intervention group (Aromatherapy group)

EXPERIMENTAL

With a mixture of Lavandula angustifolia, Rosmarinus officinalis L. and Origanum majorana L. essential oils, the foot and lower leg will be massaged for three sessions a week for 30 minutes in each session for four weeks.

Other: Lavandula angustifolia, Rosmarinus officinalis L. and Origanum majorana L.

Placebo group

EXPERIMENTAL

The foot and lower leg will be massaged with baby oil for four weeks, three sessions a week, 30 minutes in each session.

Other: Baby oil

Control group

NO INTERVENTION

No application will be made in addition to standard HD treatment.

Interventions

Massage application

Intervention group (Aromatherapy group)

Massage application

Placebo group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Above 18 years old,
  • Able to answer questions and communicate,
  • Is conscious and does not have a mental problem,
  • Speaks Turkish,
  • No hearing, sight or speech impairment,
  • Having HD treatment for at least six months,
  • Receiving three HD treatment sessions a week,
  • Dialysis with bicarbonate dialysate,
  • Kt / V value\> 1.2,
  • Having a constant dry weight for the last month,
  • Experiencing cramps during hemodialysis sessions or at any other time and who scored at least three or more when the severity of cramp pain was evaluated with the Visual Analog Scale (VAS),
  • Patients who are not allergic to the oils used for massage will be included in the study.

You may not qualify if:

  • Pregnant and breastfeeding women,
  • Cancer,
  • Diabetic foot,
  • Lower extremity amputation,
  • Having neurological diseases such as epilepsy, parkinson, dementia, Alzheimer,
  • Those with paraplegia,
  • The lower leg is in a size that prevents the application of massage,
  • had surgery in the last three months,
  • Loss of sensation more than 50% due to neuropathy due to various reasons,
  • Open wound in the foot and lower leg, infection, necrosis, fracture / fracture suspected, soft tissue damage, burn,
  • Peripheral vascular disease,
  • Deep vein thrombosis,
  • Receiving treatment to prevent cramping,
  • Having a severe electrolyte (such as potassium, magnesium, calcium) disorder in blood values,
  • Patients using any of the complementary and integrated methods in the last month will not be included in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Erciyes University

Melikgazi, Kayseri, 38260, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Muscle CrampPain

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Serife Cetin, PhD

    Kayseri University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD student

Study Record Dates

First Submitted

April 21, 2021

First Posted

May 6, 2021

Study Start

November 25, 2020

Primary Completion

December 28, 2022

Study Completion

December 28, 2022

Last Updated

January 10, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

Locations